Overview (18 Sep 2026)
Anlon Healthcare Ltd
AHCL
INE0Y8W01025
Pharmaceuticals
1.06
Prev. Close
Previous Close
21.84
Current Close
22.9
Current High
24.78
Current Low
22.11
52 Week High
172
52 Week Low
12
Resistance 1
24.41
Resistance 2
25.93
Support 1
21.74
Support 2
19.07
Std Deviation
10.52%
DMA 200
72.41
DMA 50
15.72
DMA 20
17.02
Fundamentals and Ratios
Standalone
Trailing EPS
6.11
Forwad EPS
2.43
Trailing P/E
3.75
Forward P/E
9.41
PEG Ratio
2.51
Mkt. Cap (Cr)
Market Cap (Cr)
1217.17
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A
Consolidated
Trailing EPS
6.11
Forwad EPS
2.66
Trailing P/E
3.75
Forward P/E
8.62
PEG Ratio
0.00
Mkt. Cap (Cr)
Market Cap (Cr)
1217.17
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
Book Value
163.38
P/BV Ratio
0.58
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
Consolidated
TypeJun-26Mar-26FY25-26
Revenue87.5650.89171.966
Other Income0.060.010.26
Total Income87.6250.90172.22
Interest0.920.573.74
Expenditure-73.96-36.46-129.71
PBDT0.000.000.00
Depreciation-1.07-0.29-1.52
PBT13.6614.4442.51
Tax-5.38-3.37-13.42
Equity106.3053.1553.15
OPM15.5928.3724.68
Net Profit8.2811.0729.09
NPM9.4521.7516.89
EPS0.162.336.11
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
YearRatioRemarkEx Date
20261:1Bonus issue 1:124 Apr 2026
Split
YearRatioRemarkEx Date
2026Rs.10/- to Rs.2/-Stock Split From Rs.10/- to Rs.2/-24 Apr 2026

Mutual Fund Holddings